RAD51 and neoplasm: The availability of a sensitive, non-DNA-based, method like the RAD51-FFPE test addresses this need and fills an important gap in the diagnostic landscape as, in contrast to the RECAP test, no ex vivo irradiated fresh tumor tissue is required.